Saturday, May 7, 2016

All 7 million are going to die -- depending ...

All 7 million are going to die -- unlike 3 million Hep C victims -- depending ...

HF (Heart Failure) is a terrible disease , but unfortunately is very common. It is currently poorly treated, and is one of few diseases that increase in mortality YoY. More than 7 million HF patients exist in the US, with more than 800,000 new HF cases every year. The number of HF patients is expected to exceed 10 million by 2030. The HF increase in prevalence is driven by the epidemics of obesity, diabetes, and high blood pressure. Additionally, 7-10% of the aging population above 65 years old suffer from HF."   

Sunshine Heart (NASDAQ:SSH) said it had halted enrolment in the pivotal US trial of its heart failure device C-Pulse to focus on a “more optimal” clinical strategy that ought to get it to market more quickly. It will need some luck."   

"The device, developed by Sunshine Heart Inc., is an extra-aortic counterpulsation system. It consists of a cuff that is placed around the patient's aorta - the largest artery in the body - and is outside of the patient's bloodstream. The cuff is attached to a small balloon that inflates and deflates in sync with the patient's heartbeat. This pumps blood through the aorta and around the body" 

"After the 20 were treated with the C-Pulse device, most of them were able to come down a point or two in heart failure class. In other words, some heart patients went from being Class III heart failure patients to Class II or Class I, some from Class IV to Class I and some stayed in their class and the disease didn’t progressively worsen, Rosa said."

Seems we cannot cure the 7 million for the opposite reason we cannot cure the 3 million.  Unlike the $300 billion that Gilead wants for a Sovaldi cure for all, Sunshine has no been able so far raise the $20-30 million for the trials for C-Pulse technology which  cured(!) 5 of 20 patients in the first trial, ending 2012 and improved or kept steady the rest.  All very sick people.

C-Pulse money problem is reportedly that investors are afraid any patent to the technology may be too easy to bypass by other  manufacturers.

No comments: